Antoniou et al. developed a hypergeometric polygenic BOADICEA model for populations with a known family history of breast or ovarian cancer by incorporating BRCA1 and BRCA2 mutations, as well as the joint multiplicative effects of a polygenic component of multiple genes of small effect [59]. The gene discussed is BRCA2; the disease is ovarian cancer.